Stockreport

TG Therapeutics outlines $825M–$850M BRIUMVI 2026 guidance while accelerating subcutaneous program [Seeking Alpha]

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF Michael Weiss, Chairman, CEO & President, stated that 2025 was a defining year for TG Therapeutics, emphasizing, "We delivered approximately $616 million in total globa [Read more]